| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.34 | 0.06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |